Report cover image

Hepatic Encephalopathy Global Market Report 2025

Publisher The Business Research Company
Published Mar 04, 2025
Length 200 Pages
SKU # BRC19723035

Description

Hepatic Encephalopathy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hepatic encephalopathy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for hepatic encephalopathy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hepatic encephalopathy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Drug Class: Antibiotics; Laxatives; L-Ornithine; L-Aspartate; Other Drug Classes

2) By Route Of Administration: Oral; Intravenous; Rectal 

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:

1) By Antibiotics: Rifaximin; Neomycin; Metronidazole

2) By Laxatives: Lactulose; Polyethylene Glycol; Sorbitol

3) By L-Ornithine, L-Aspartate: L-Ornithine L-Aspartate

4) By Other Drug Classes: Zinc Supplements; Probiotics; Hepatoprotective Agents

Companies Mentioned: Umecrine Cognition AB; Bausch Health Companies Inc.; Mallinckrodt Pharmaceuticals; Lupin Limited; Salix Pharmaceuticals

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

200 Pages
1. Executive Summary
2. Hepatic Encephalopathy Market Characteristics
3. Hepatic Encephalopathy Market Trends And Strategies
4. Hepatic Encephalopathy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Hepatic Encephalopathy Growth Analysis And Strategic Analysis Framework
5.1. Global Hepatic Encephalopathy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Hepatic Encephalopathy Market Growth Rate Analysis
5.4. Global Hepatic Encephalopathy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Hepatic Encephalopathy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Hepatic Encephalopathy Total Addressable Market (TAM)
6. Hepatic Encephalopathy Market Segmentation
6.1. Global Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antibiotics
Laxatives
L-Ornithine
L-Aspartate
Other Drug Classes
6.2. Global Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Rectal
6.3. Global Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Hepatic Encephalopathy Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rifaximin
Neomycin
Metronidazole
6.5. Global Hepatic Encephalopathy Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lactulose
Polyethylene Glycol
Sorbitol
6.6. Global Hepatic Encephalopathy Market, Sub-Segmentation Of L-Ornithine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
L-Aspartate
L-Ornithine L-Aspartate
6.7. Global Hepatic Encephalopathy Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Zinc Supplements
Probiotics
Hepatoprotective Agents
7. Hepatic Encephalopathy Market Regional And Country Analysis
7.1. Global Hepatic Encephalopathy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Hepatic Encephalopathy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Hepatic Encephalopathy Market
8.1. Asia-Pacific Hepatic Encephalopathy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Hepatic Encephalopathy Market
9.1. China Hepatic Encephalopathy Market Overview
9.2. China Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Hepatic Encephalopathy Market
10.1. India Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Hepatic Encephalopathy Market
11.1. Japan Hepatic Encephalopathy Market Overview
11.2. Japan Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Hepatic Encephalopathy Market
12.1. Australia Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Hepatic Encephalopathy Market
13.1. Indonesia Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Hepatic Encephalopathy Market
14.1. South Korea Hepatic Encephalopathy Market Overview
14.2. South Korea Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Hepatic Encephalopathy Market
15.1. Western Europe Hepatic Encephalopathy Market Overview
15.2. Western Europe Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Hepatic Encephalopathy Market
16.1. UK Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Hepatic Encephalopathy Market
17.1. Germany Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Hepatic Encephalopathy Market
18.1. France Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Hepatic Encephalopathy Market
19.1. Italy Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Hepatic Encephalopathy Market
20.1. Spain Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Hepatic Encephalopathy Market
21.1. Eastern Europe Hepatic Encephalopathy Market Overview
21.2. Eastern Europe Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Hepatic Encephalopathy Market
22.1. Russia Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Hepatic Encephalopathy Market
23.1. North America Hepatic Encephalopathy Market Overview
23.2. North America Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Hepatic Encephalopathy Market
24.1. USA Hepatic Encephalopathy Market Overview
24.2. USA Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Hepatic Encephalopathy Market
25.1. Canada Hepatic Encephalopathy Market Overview
25.2. Canada Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Hepatic Encephalopathy Market
26.1. South America Hepatic Encephalopathy Market Overview
26.2. South America Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Hepatic Encephalopathy Market
27.1. Brazil Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Hepatic Encephalopathy Market
28.1. Middle East Hepatic Encephalopathy Market Overview
28.2. Middle East Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Hepatic Encephalopathy Market
29.1. Africa Hepatic Encephalopathy Market Overview
29.2. Africa Hepatic Encephalopathy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Hepatic Encephalopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Hepatic Encephalopathy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Hepatic Encephalopathy Market Competitive Landscape And Company Profiles
30.1. Hepatic Encephalopathy Market Competitive Landscape
30.2. Hepatic Encephalopathy Market Company Profiles
30.2.1. Umecrine Cognition AB Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Mallinckrodt Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Lupin Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Salix Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
31. Hepatic Encephalopathy Market Other Major And Innovative Companies
31.1. Norgine B.V.
31.2. Ferring B.V.
31.3. ASKA Pharmaceutical Co. Ltd.
31.4. Vedanta Biosciences Inc.
31.5. Gilead Sciences Inc.
31.6. Amgen Inc.
31.7. Teva Pharmaceutical Industries Ltd.
31.8. Mylan N.V.
31.9. Bausch Health Companies Inc.
31.10. Ochsner Health Inc.
31.11. Sun Pharmaceutical Industries Ltd.
31.12. Dr. Reddy's Laboratories Ltd.
31.13. Cipla Limited
31.14. Amneal Pharmaceuticals LLC
31.15. Mallinckrodt Plc
32. Global Hepatic Encephalopathy Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Hepatic Encephalopathy Market
34. Recent Developments In The Hepatic Encephalopathy Market
35. Hepatic Encephalopathy Market High Potential Countries, Segments and Strategies
35.1 Hepatic Encephalopathy Market In 2029 - Countries Offering Most New Opportunities
35.2 Hepatic Encephalopathy Market In 2029 - Segments Offering Most New Opportunities
35.3 Hepatic Encephalopathy Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us